Sanitary requirements for export of (processed) porcine blood to Korea HA 2111 (Amended October 2, 2014)
Canada has been free of FMD, vesicular stomatitis, swine vesicular disease for 2 years prior to export and is free from rinderpest, peste des petits ruminants, contagious bovine pleuropneumonia, rift valley fever, sheep pox, African swine fever and lumpy skin disease for 3 years prior to export. Vaccination against these diseases is prohibited in Canada.
The product has been processed in an establishment operating under permit issued by the Canadian Food Inspection Agency (CFIA) and which is dedicated to porcine material.
The product originates from animals that have been slaughtered in a slaughterhouse approved by the CFIA and which passed ante mortem and were presented for post mortem inspection by the CFIA.
The product is exclusively of porcine origin. No material of ruminant origin is included in the preparation of processed porcine blood.
The product has been submitted to a minimum temperature of 80 degrees Celsius throughout its substance.
The product is not mixed with imported material from third countries.
Each shipment to Korea is negative for the presence of ruminant protein.
The product was stored for over 3 weeks (including the transport time) at room temperature, processed and transported in such a manner as to prevent contamination by communicable animal disease pathogens.